18.01.2024 - DUBLIN, Ireland, Jan. 18, 2024 (GLOBE NEWSWIRE) - GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced that it recently . Seite 1